Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.

Cancer - 1 Apr 2013

Domchek Susan M, Jhaveri Komal, Patil Sujata, Stopfer Jill E, Hudis Clifford, Powers Jacquelyn, Stadler Zsofia, Goldstein Laura, Kauff Noah, Khasraw Mustafa, Offit Kenneth, Nathanson Katherine L, Robson Mark

Abstract excerpt

BACKGROUND: This study sought to estimate the risk of breast cancer (BC) after a diagnosis of ovarian cancer (OC) associated with mutation of the BRCA1/2 (breast cancer, early onset) genes (BRCA-OC). METHODS: The Memorial Sloan-Kettering Cancer Center and the University of Pennsylvania, clinical genetics databases were searched to identify women with BRCA-OC who participated in genetic testing and follow-up...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Neoplasms, Second Primary

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 23165893
DOI: 10.1002/cncr.27842

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.PMID 23165893Read ↗

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Breast cancer following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis.Semantic proximity Read ↗

The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.Semantic proximity Read ↗

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.Semantic proximity Read ↗

Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.Semantic proximity Read ↗

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.Semantic proximity Read ↗

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.Semantic proximity Read ↗

Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.